Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

2articles mentioning drugs

5drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: GPC3 ×

GPC3

This drug is selected. Its supporting articles are shown below.

Articles mentioning GPC3

2 articles · page 1 of 1

300 Therapeutic potential of allogeneic CAR-expressing iNKT cells in preclinical models for tumors and autoimmune diseases

jitc · abstract · 2025-11-04 · 3 matching annotations

81.0%

GPC3 cancer ALL autoimmune diseases CLL SLE GvHD NSG mice graft-versus-host disease Medicilon’s Ethics Board

…ys prior to treatment with three tail vein injections of 18×106 GPC3 CAR-iNKT cells (50% CAR+) or untransduced iNKT cells on days 3,…

IDDF2026-ABS-0094 Clinical outcomes and safety of GPC3-directed CAR-T therapy in advanced hepatocellular carcinoma: a systematic review of early-phase trials

gutjnl · abstract · 2026-06-26 · 2 matching annotations

80.8%

GPC3 Glypican-3 Hepatocellular carcinoma HCC PubMed Chimeric antigen receptor T-cell (CAR-T) therapy GPC3-directed CAR-T therapy Google Scholar

…imeric antigen receptor T-cell (CAR-T) therapy directed against GPC3 has shown early antitumor activity in phase I trials; however, …